AMYLYX PHARMACEUTICALS
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain. The company features a drug designed to prevent nerve cell death and degeneration.
AMYLYX PHARMACEUTICALS
Industry:
Biotechnology Medical Neuroscience Pharmaceutical
Founded:
2014-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.amylyx.com
Total Employee:
251+
Status:
Active
Total Funding:
448.45 M USD
Technology used in webpage:
Google Google Cloud DNSSEC Facebook Sharer Microsoft AWS Global Accelerator Amazon Route 53 Microsoft Azure Google Cloud Global Multi-Region Mailgun
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Arrakis Therapeutics
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
Braingrade
Braingrade developing a new solution for patients with Alzheimer’s Disease.
Cure Alzheimer's Fund
Cure Alzheimer's Fund is involved in the funding of the research on preventing, slowing and reversing Alzheimer's disease.
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals focuses on improving kinase inhibitor treatments.
Kala Pharmaceuticals
Kala Pharmaceuticals develops novel treatments for diseases that affect mucosal tissues.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Board_member
2015-03-01
Board_member
2015-01-01
Current Employees Featured
Justin Klee President and Founder @ Amylyx Pharmaceuticals
President and Founder
2013-01-01
Joshua Cohen CEO and Founder @ Amylyx Pharmaceuticals
CEO and Founder
Gina M. Mazzariello Chief Legal Officer & General Counsel @ Amylyx Pharmaceuticals
Chief Legal Officer & General Counsel
2022-02-01
Camille Bedrosian Chief Medical Officer @ Amylyx Pharmaceuticals
Chief Medical Officer
2023-11-01
Jim Frates Chief Financial Officer @ Amylyx Pharmaceuticals
Chief Financial Officer
2021-01-01
Timothy Lee 2nd Commercial Member - Pre IPO - Pre Commercialization @ Amylyx Pharmaceuticals
2nd Commercial Member - Pre IPO - Pre Commercialization
2020-02-01
Founder
Stock Details
Investors List
683 CAPITAL
683 CAPITAL investment in Series C - Amylyx Pharmaceuticals
aMoon Fund
aMoon Fund investment in Series C - Amylyx Pharmaceuticals
Perceptive Advisors
Perceptive Advisors investment in Series C - Amylyx Pharmaceuticals
Woodline Partners
Woodline Partners investment in Series C - Amylyx Pharmaceuticals
Verition Fund Management
Verition Fund Management investment in Series C - Amylyx Pharmaceuticals
Morningside Venture Investments
Morningside Venture Investments investment in Series C - Amylyx Pharmaceuticals
Polaris Founders Capital
Polaris Founders Capital investment in Series C - Amylyx Pharmaceuticals
Belinda Termeer
Belinda Termeer investment in Series C - Amylyx Pharmaceuticals
Marshall Wace
Marshall Wace investment in Series C - Amylyx Pharmaceuticals
Tybourne Capital Management
Tybourne Capital Management investment in Series C - Amylyx Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.amylyx.com Semrush global rank: 2.1 M Semrush visits lastest month: 9.71 K
- Host name: ec2-3-234-100-195.compute-1.amazonaws.com
- IP address: 3.234.100.195
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Amylyx Pharmaceuticals"
Careers - Amylyx
Our programs ensure you have robust coverage. We offer a PPO (Preferred Provider Organization) medical plan and an HMO (Health Maintenance Organization). Our PPO plan is …See details»
Leadership Team - Amylyx
Progress is made possible thanks to the passion and drive of every Amylyx team member, and we promise to strive to always be true partners to the people and communities affected by these …See details»
Amylyx Pharmaceuticals - Wikipedia
Amylyx Pharmaceuticals was founded in 2013 by Joshua Cohen and Justin Klee when the two were undergraduate students at Brown University. The two proposed that taurursodiol and sodium phenylbutyrate together might prevent dysfunction of mitochondria and the endoplasmic reticulum, safeguarding neurons. Klee and Cohen were advised by Rudolph E. Tanzi, who ultimately served as the founding chair of Amylyx's scientific research board. After Klee and Cohen were able to a…See details»
Amylyx Pharmaceuticals - Crunchbase Company …
Organization. Amylyx Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Amylyx Pharmaceuticals reported robust revenue growth and net income for …See details»
Amylyx - The Org
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain. Industries. Biotechnology, Health Care +2. Headquarters. Cambridge, United States. …See details»
Amylyx Pharmaceuticals - LinkedIn
Amylyx Pharmaceuticals | 68,834 followers on LinkedIn. Amylyx Pharmaceuticals, Inc. is a global company committed to the mission of discovery and development of treatments for relentless …See details»
SEC Filings | Amylyx Pharmaceuticals, Inc.
3 days ago The Investor Relations website contains information about Amylyx Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Amylyx Pharmaceuticals, Inc. (AMLX) - Yahoo Finance Canada
Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts. Corporate Governance . Amylyx Pharmaceuticals, Inc.’s ISS Governance …See details»
Amylyx Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. Amylyx Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Contacts 217. About. Amylyx Pharmaceuticals has 6 current …See details»
Events & Presentations | Amylyx Pharmaceuticals, Inc.
Oct 17, 2024 Amylyx Pharmaceuticals Avexitide Acquisition Conference Call Presentation. Upcoming Events. There are no upcoming events scheduled at this time. Past Events. Dec 4, …See details»
Our Company - Amylyx
Amylyx is a global pharmaceutical company based in Cambridge, Massachusetts, that is dedicated to the discovery and development of potential treatments for neurodegenerative …See details»
Amylyx Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 Amylyx has 3 employees across 8 locations and $380.79 m in annual revenue in FY 2023. See insights on Amylyx including office locations, competitors, revenue, financials, …See details»
Amylyx's ALS drug finally scores FDA approval, but that's just the …
Sep 29, 2022 Amylyx isn’t the only one tuned into these issues. The ALS Association is also celebrating the approval. That organization invested $2.2 million of funds raised through …See details»
Amylyx Pharmaceuticals - Overview, News & Similar companies
May 9, 2024 Director Karen Firestone Acquires 50,000 Shares of Amylyx Pharmaceuticals Inc (AMLX) Following this transaction, the insider now owns a total of 55,000 shares of Amylyx …See details»
Chutes & Ladders—Amylyx preps for GLP-1 launch with new CCO
23 hours ago Monahan first joined Amylyx in February 2024 as general manager and head of U.S. commercial markets. Before his three years at Otsuka, Monahan held roles at Sanofi and …See details»
Amylyx Pharmaceuticals Prices Offering Of Approx. 17.1 Mln
20 hours ago (RTTNews) - Amylyx Pharmaceuticals, Inc. (AMLX), a Massachusetts-based biopharmaceutical company, Friday announced the pricing of an underwritten public offering of …See details»
Amylyx Pharma Commences Underwritten Public Offering Of Shares
1 day ago Amylyx noted that it plans to use the net proceeds from the offering, together with existing cash, cash equivalents and marketable securities, to advance preparations for …See details»
Amylyx Pharmaceuticals Appoints Dan Monahan as Chief …
5 days ago CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the appointment of Dan Monahan as …See details»
Amylyx Pharmaceuticals Announces Pricing of Public Offering of …
23 hours ago CAMBRIDGE, Mass., January 10, 2025--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") today announced the pricing of an underwritten public …See details»
Amylyx Pharmaceuticals Appoints Dan Monahan as Chief …
4 days ago Amylyx is committed to the discovery and development of new treatment options for communities with high unmet needs, including people living with serious and fatal …See details»